The shares of Medtronic plc (NYSE:MDT) traded with a loss of -0.06 points or -0.07% in the most recent session. The shares last traded at $84.41. As per the trading info, the shares saw $37.29 million in upticks and lost $28.74 million in downticks, resulting in a net money flow of $8.55 million. The up/down ratio for the day was measured at 1.3. For the week, the shares had posted 0.32%.From the block trade data available, the total upticks were valued at $11.66 million and the total downticks were valued at $1.39 million, thereby putting the up/down ratio at 8.36. The net money flow for the block transaction was $10.26 million.
The stock has recorded a 20-day Moving Average of 1.67% and the 50-Day Moving Average is 4.64%. The company shares have rallied 10.26% in the past 52 Weeks. On June 13, 2016 The shares registered one year high of $86.31 and one year low was seen on August 24, 2015 at $55.54. The 50-day moving average is $81.98 and the 200 day moving average is recorded at $77.68. S&P 500 has rallied 1.93% during the last 52-weeks.
Medtronic plc (NYSE:MDT): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $84.84 and $83.93 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $84.98. The buying momentum continued till the end and the stock did not give up its gains. It closed at $84.59, notching a gain of 0.14% for the day. The total traded volume was 4,925,047 . The stock had closed at $84.47 on the previous day.
Currently the company Insiders own 0.21% of Medtronic plc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -4.03% . Institutional Investors own 82.76% of Medtronic plc shares. During last six month period, the net percent change held by insiders has seen a change of -5.04%. On the companys insider trading activities,The officer (SrVP & Chief Scien, Clin, Reg) of Medtronic Plc, Kuntz Richard sold 49,905 shares at $82.6 on June 3, 2016. The Insider selling transaction had a total value worth of $4,122,153. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.